In the copper belt of Katanga, a province in the southeastern Democratic Republic of Congo, the dust is everywhere. It coats the leaves of mango trees, settles on the tin roofs of miners' homes, and, most dangerously, fills the air underground. For decades, men have gone down into the shafts to dig copper and cobalt, breathing in silica and metal dust with every shift. The dust stays in their lungs long after they surface, slowly turning healthy tissue into scarred, stiffened mass. Miners call it "the cough that stays."

A Dust That Never Leaves the Lungs

The mines around Lubumbashi, the provincial capital, and the towns of Kolwezi and Likasi form one of the world's richest mineral deposits. Copper and cobalt are extracted from open pits and underground galleries, often by artisanal miners who work with little protective gear. The rock they drill and blast contains crystalline silica, a known cause of silicosis, and cobalt, which has been linked to a distinct form of lung disease, sometimes called "cobalt lung."

Over years of exposure, the dust particles lodge in the alveoli, the tiny air sacs where oxygen enters the blood. The body's immune system responds with inflammation, and then with fibrosis, a scarring process that makes the lungs less elastic. This is pneumoconiosis, a family of occupational lung diseases that includes silicosis, coal workers' pneumoconiosis, and cobalt-related interstitial disease. The scarring is irreversible and progressive, even after exposure stops.

Autopsy studies from the region, though limited, have shown the damage. A 2018 study by Nkulu and colleagues, published in the International Journal of Environmental Research and Public Health, examined lung tissue from 44 deceased miners in the DRC and found fibrotic scarring consistent with silicosis in 27 of them. Similar findings have been reported in South African miners, where decades of autopsy data have documented the toll of dust exposure. In Katanga, however, the disease is rarely diagnosed before death, because it develops silently over 10 to 20 years, with no early symptoms. By the time a miner feels short of breath, a large part of the lung is already scarred.

Miners describe the progression in local terms: first, a dry cough that they ignore; then, breathlessness on the way to work; finally, an inability to walk the few kilometres to the mine. Many attribute the symptoms to age, or to smoking, or to a curse. The dust, they say, is just part of the job.

Clinics Count TB Cases, Not Pneumoconiosis

The lung clinics that serve these mining communities are organised around a single priority: tuberculosis. In Lubumbashi, the provincial TB program reports hundreds of new cases each year, and the national strategy, aligned with the World Health Organization, focuses on detecting and treating smear-positive TB. Clinics have microscopes, sputum collection kits, and trained laboratory technicians. What they do not have are spirometers, or even a simple question about a patient's occupation.

A miner who arrives at a clinic with a chronic cough and weight loss is almost automatically presumed to have TB. If his sputum is negative for acid-fast bacilli, he may be labelled "smear-negative TB" and started on a full course of antibiotics. When he does not improve, the drugs are repeated, or he is referred to a hospital for an X-ray. The X-ray, however, cannot reliably distinguish silicosis from TB. Both produce nodules and scarring on the film, and without a detailed occupational history, a radiologist may read the image as consistent with TB.

The result is a systematic misclassification. Patients with pneumoconiosis are treated for TB, often multiple times, and their true condition goes unrecorded. The national program reports only TB numbers, so the burden of dust disease remains invisible to policymakers. As one clinician in Lubumbashi told me, "We count what we can test for. We cannot test for dust."

This is not a failure of individual clinicians, but of the system's design. TB is an acute, infectious disease with a clear diagnostic pathway and a funded treatment program. Pneumoconiosis is a chronic, non-communicable disease that requires a different set of tools and a different kind of follow-up. In a setting where resources are scarce, the acute disease wins attention.

The Evidence Gap: What Research Shows

International research has long established the link between dust exposure and premature death. The most cited data come from South Africa, where the autopsy registry of the National Institute for Occupational Health has shown that silicosis is a major cause of death among gold miners. Studies of copper and cobalt miners elsewhere have also documented elevated rates of lung fibrosis and lung cancer. In the DRC, however, the evidence is thinner.

A few cross-sectional studies have been conducted in Katanga. One survey of artisanal copper miners in the Kolwezi area, conducted by the University of Lubumbashi's School of Public Health in 2015, found that 38% of 210 miners had respiratory symptoms and 22% had abnormal chest X-rays, but the sample was small and the follow-up was limited. Another study of cobalt workers, published in 1995 by Nemery and colleagues in the European Respiratory Journal, described a syndrome of hard-metal lung disease, with cough, dyspnoea, and fibrosis. These studies are cited in occupational health textbooks, but they have not translated into local practice.

What is missing is a longitudinal cohort study that follows miners from the start of their careers to retirement or death. Without such data, it is impossible to quantify the risk, to identify the most hazardous jobs, or to calculate the years of life lost. The International Labour Organization's classification for radiographs of pneumoconiosis is well established, but it is rarely used in Katanga, where most clinics do not even have a reader trained in the system.

Researchers argue that this evidence gap is itself a form of neglect. The mines are among the most profitable in the world, generating billions of dollars in revenue, yet the health of the workers who extract the ore is poorly documented. As one occupational health specialist put it, "We have better data on the cobalt content of the ore than on the lungs of the men who dig it."

Why Diagnosis Fails at the Bedside

Even when a clinician suspects pneumoconiosis, making a diagnosis is difficult. The first barrier is training. Nurses and doctors in Katanga receive minimal instruction in occupational health. A typical nursing curriculum includes a few hours on "occupational diseases," but it is not a priority. Many clinicians have never seen a spirometer and do not know how to interpret a restrictive or obstructive pattern.

Second, miners present late. Because the disease progresses slowly, they do not seek care until they are severely breathless. By then, the lungs are extensively scarred, and the diagnosis is clinically obvious, but the damage is done. Early detection, which could slow the progression by removing the worker from exposure, is rare.

Third, there is stigma. In the mining communities, a diagnosis of "dust lungs" can be seen as a sign of weakness, or as an accusation against the company that employs you. Miners may hide their symptoms for fear of losing their jobs or being moved to lower-paying surface work. Some companies do not provide health care, and a formal diagnosis of occupational disease could complicate compensation claims, so workers often prefer the vague label of "chronic cough."

Finally, clinicians lack the tools and the incentives. Spirometers are expensive and require calibration and training. Occupational history forms are not part of the standard clinical record. And there is no treatment for pneumoconiosis other than supportive care and oxygen, so diagnosing it may seem futile. As one doctor explained, "If I diagnose silicosis, what can I offer? I cannot reverse the fibrosis. I can only tell him to stop mining, and then he has no income."

The Cost of Missed Diagnosis

The failure to diagnose pneumoconiosis has profound consequences, for individuals and for the health system. Miners die younger. A study in South Africa estimated that silicosis reduces life expectancy by several years, and similar effects are likely in Katanga, where HIV and TB are also common. Families lose their primary breadwinner, often in the prime of life, and fall into poverty.

The health system pays later, and more. A miner with undiagnosed silicosis is treated repeatedly for TB. Each course of antibiotics costs money, and when the drugs fail, the patient may be hospitalised, incurring further costs. The repeated exposure to anti-TB drugs also carries risks, including drug resistance. Meanwhile, the underlying lung disease progresses, and the patient eventually dies of respiratory failure, a death that is never attributed to the dust.

There is also a broader economic cost. Katanga's copper and cobalt are essential for the global transition to electric vehicles, but the productivity of the mining workforce is diminished by chronic respiratory disease. Miners who are breathless cannot work at full capacity, and they retire earlier, reducing the region's output. Some economists have argued that occupational health is a productivity issue, not just a humanitarian one.

The cost is also borne by the community. When a miner dies, his widow and children may lose their home and their access to education. The social safety net is thin, and the extended family is stretched. In a region where mining is the main source of employment, the loss of a skilled worker is felt by everyone.

What a Practical Response Looks Like

Addressing this gap does not require a high-tech solution. A first step would be to add a simple question to the TB screening form: "Have you ever worked in a mine, quarry, or other dusty job?" This would flag patients at risk and prompt a more detailed occupational history. It costs nothing and can be done by any nurse.

Second, handheld spirometers, which cost a few hundred dollars, could be placed in the clinics that serve mining communities. Spirometry can detect restrictive lung disease before symptoms appear, and it is a simple test that can be performed by a trained nurse. The results could be used to counsel miners about the risks of continued exposure and to monitor disease progression.

Third, nurses and clinical officers need training in occupational history taking. A short module, perhaps a day or two, would teach them how to ask about dust exposure, how to interpret the answers, and how to document the findings. This training could be integrated into the existing TB and HIV programs, which already have a strong presence in the region.

Fourth, a pilot compensation program could be developed. In South Africa, the Occupational Diseases in Mines and Works Act provides compensation for miners with silicosis, and similar schemes exist in other countries. In the DRC, no such program exists, but a pilot in one or two mining companies could test the feasibility and the cost. Compensation would provide some financial security for affected workers and would also create an incentive for companies to reduce dust exposure.

Finally, mining companies should be linked to local health data. Currently, companies often operate in isolation, and health surveillance, if any, is done by private clinics that do not share data with the public system. A partnership between companies, the Ministry of Health, and research institutions could establish a simple registry of miners and their respiratory health, enabling early detection and long-term follow-up.

From Counting Cases to Counting Lives

The shift from acute to chronic lung care will not be easy. It requires a change in mindset, from counting TB cases to counting lives lost to dust. It also requires investment, but the cost is modest compared to the cost of treating repeated TB failures or compensating for lost productivity. Some may argue that in a country with so many pressing health needs, pneumoconiosis is a low priority. But the miners are citizens, and their disease is preventable.

There are also opportunities for research. A cohort study of miners in Katanga could provide the data needed to quantify the burden and to advocate for dust controls. Such a study could be conducted in partnership with universities in the DRC and abroad, and it could be funded by the mining industry or by international donors. The findings would inform policy not only in the DRC but in other mining regions across Africa and beyond.

Yet, even with better data, the fundamental challenges remain. Clinicians are overworked, drugs are in short supply, and the health system is fragile. The miners, for their part, may be reluctant to be labelled with a disease that could cost them their jobs. Any intervention must be designed with these realities in mind, and it must be sensitive to the social and economic pressures that miners face.

Moreover, the proposed interventions themselves carry risks and trade-offs. Adding spirometry to already overloaded clinics could divert staff time from TB case detection, potentially increasing transmission in a region where TB is endemic. Training nurses in occupational health might raise expectations among miners that the health system cannot meet, leading to frustration and distrust. A compensation program, if poorly designed, could create perverse incentives: companies might avoid hiring workers with any respiratory symptoms, or they might pressure doctors to under-diagnose to limit payouts. And without strong governance, a registry of miners' health data could be misused for discrimination or as a tool for surveillance rather than care.

These are not arguments against action, but they are reasons to proceed cautiously and with the full participation of miners and their communities. The goal is not merely to diagnose pneumoconiosis, but to treat the person. That means providing oxygen, physiotherapy, and palliative care for those who are already scarred. It means preventing further exposure for those who are still working. And it means acknowledging, in the official statistics, that dust disease exists. Only then can the health system begin to count lives, not just cases.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.